Page last updated: 2024-11-02

phenylbutazone and Corneal Opacity

phenylbutazone has been researched along with Corneal Opacity in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KERSLEY, GD1
OPPEL, O1

Other Studies

2 other studies available for phenylbutazone and Corneal Opacity

ArticleYear
COMPLICATIONS OF NON-STEROID TREATMENT OF RHEUMATOID ARTHRITIS.
    Annals of physical medicine, 1964, Volume: 8

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Antimalarials; Arthritis; Arthritis, Rheumatoi

1964
[EYE INVOLVEMENT IN TOXICODERMA].
    Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft, 1964, Volume: 65

    Topics: Aminopyrine; Corneal Opacity; Corneal Ulcer; Drug Hypersensitivity; Exanthema; Phenylbutazone; Skin

1964